Evidence map›Paper›PMID 16705163›Full record

ArticleMolecular and cellular biology2006

SWI/SNF binding to the HO promoter requires histone acetylation and stimulates TATA-binding protein recruitment.

Doyel Mitra, Emily J Parnell, Jack W Landon, Yaxin Yu, David J Stillman

Open access · greenAbstract read
In one paragraph

Article in Molecular and cellular biology, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 63 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Stochastic expression and epigenetic memory at the yeast HO promoter.Proceedings of the National Academy of Sciences of the United States of America · 2013
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Doyel MitraDepartment of Pathology, University of Utah, 15 North Medical Drive East, Salt Lake City, UT 84132-2501, USA.
Emily J Parnell
Jack W Landon
Yaxin Yu
David J Stillman
University of Utah · US

Funding

RESEARCH TRAINING IN HEMATOLOGYT32DK007115 · NIDDK · UNIVERSITY OF UTAH · PI LEIBOLD, ELIZABETH ANN, PRCHAL, JOSEF T · 1986 to 2020
$8.4M
TRAINING PROGRAM IN GENETICST32GM007464 · NIGMS · UNIVERSITY OF UTAH · PI GRUNWALD, DAVID J., STANFIELD, GILLIAN · 1985 to 2020
$6.1M
NIDDK NIH HHS T32 DK007115NIDDK NIH HHS T32-DK007115NIGMS NIH HHS T32 GM007464NIGMS NIH HHS T32-GM007464
6 · The paper itself

Abstract

We use chromatin immunoprecipitation assays to show that the Gcn5 histone acetyltransferase in SAGA is required for SWI/SNF association with the HO promoter and that binding of SWI/SNF and SAGA are interdependent. Previous results showed that SWI/SNF binding to HO was Gcn5 independent, but that work used a strain with a mutation in the Ash1 daughter-specific repressor of HO expression. Here, we show that Ash1 functions as a repressor that inhibits SWI/SNF binding and that Gcn5 is required to overcome Ash1 repression in mother cells to allow HO transcription. Thus, Gcn5 facilitates SWI/SNF binding by antagonizing Ash1. Similarly, a mutation in SIN3, like an ash1 mutation, allows both HO expression and SWI/SNF binding in the absence of Gcn5. Although Ash1 has recently been identified in a Sin3-Rpd3 complex, our genetic analysis shows that Ash1 and Sin3 have distinct functions in regulating HO. Analysis of mutant strains shows that SWI/SNF binding and HO expression are correlated and regulated by histone acetylation. The defect in HO expression caused by a mutant SWI/SNF with a Swi2(E834K) substitution can be partially suppressed by ash1 or spt3 mutation or by a gain-of-function V71E substitution in the TATA-binding protein (TBP). Spt3 inhibits TBP binding at HO, and genetic analysis suggests that Spt3 and TBP(V71E) act in the same pathway, distinct from that of Ash1. We have detected SWI/SNF binding at the HO TATA region, and our results suggest that SWI/SNF, either directly or indirectly, facilitates TBP binding at HO.

Indexed as

AcetylationAdenosine TriphosphatasesAllelesCatalysisCell Cycle ProteinsChromosomal Proteins, Non-HistoneDeoxyribonucleases, Type II Site-SpecificDNA-Binding ProteinsFungal ProteinsGene Expression Regulation, FungalHistone AcetyltransferasesHistone DeacetylasesHistonesModels, BiologicalMutationp300-CBP-Associated FactorAdenosine TriphosphatasesASH1 protein, S cerevisiaeCell Cycle ProteinsChromosomal Proteins, Non-HistoneDeoxyribonucleases, Type II Site-SpecificDNA-Binding ProteinsFungal ProteinsGCN5 protein, S cerevisiaeHistone AcetyltransferasesHistone DeacetylasesHistonesHO protein, S cerevisiaep300-CBP-Associated FactorRepressor ProteinsSaccharomyces cerevisiae ProteinsSCEI protein, S cerevisiaeSIN3 protein, S cerevisiaeSNF2 protein, S cerevisiaeSWI5 protein, S cerevisiaeSWI-SNF-B chromatin-remodeling complexTATA-Box Binding ProteinTranscription Factors

Identifiers

PMID16705163
PMCPMC1489090
OpenAlexW2166737726

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.